Home/Pipeline/Dermatology Candidates

Dermatology Candidates

Dermatology

Not SpecifiedActive R&D

Key Facts

Indication

Dermatology

Phase

Not Specified

Status

Active R&D

Company

Aucta Pharmaceuticals

About Aucta Pharmaceuticals

Aucta Pharmaceuticals is a private, US-based specialty pharma company with a dual-site R&D and manufacturing presence in New Jersey and Shanghai. Its strategy centers on using its proprietary AucPed, AucTrol, and AucMist technology platforms to create differentiated dosage forms of established drugs, aiming to improve patient adherence and outcomes. The company is backed by a consortium of global and China-based healthcare investors and is advancing a pipeline focused on CNS and orphan diseases.

View full company profile

Therapeutic Areas

Central Nervous System (CNS) Disorders Metabolic Diseases Orphan and Specialty Indications Ophthalmics Dermatology Pediatrics

Other Dermatology Drugs

Drug	Company	Phase	Status
Not specified in provided content	3Sbio	Various	Active
Tretinoin Gel	Avecho Biotechnology	Preclinical	Active
PCI for Nucleic Acid Delivery	PCI Biotech	Preclinical	Terminated (Liquidation)
Undisclosed Transcription Factor Program	Montai Therapeutics	Development Candidate (DC) expected 2026	Active
Undisclosed Biologic Replacement Program	Montai Therapeutics	Development Candidate (DC) expected 2027	Active